在医疗保险中与癌症相关的下一代测序的索赔拒绝
So-Yeon Kang1, Ilina Odouard2, Carole Roan Gresenz1,3
1Department of Health Management and Policy, Georgetown University School of Health, Washington, DC.
JAMA network open
|April 18, 2025
概括
在国家覆盖确定 (NCD) 后,下一代测序 (NGS) 癌症测试的保险索赔拒绝增加. 对于在独立实验室进行的测试和更全面的基因组分析,否认率更高.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 美国医疗保险和医疗补助服务中心 (CMS) 在2018年为下一代测序 (NGS) 基因测试制定了国家覆盖率确定 (NCD),并于2020年修订.
- 了解NGS保险索赔拒绝的频率和原因对于患者获取和医疗保健费用至关重要.
研究的目的:
- 调查Medicare受益人中NGS测试索赔拒绝的普遍性和相关因素.
- 分析NCD实施和修订如何影响NGS测试索赔拒绝率.
主要方法:
- 一项队列研究分析了2016年至2021年20%的医疗保险索赔数据样本.
- 多变量后勤回归模型确定了与索赔拒绝相关的因素,包括与NCD相对的测试类型,地点和时间段.
主要成果:
- 与癌症相关的NGS测试索赔从2016年到2021年大幅增加.
- 整体索赔拒绝率为23.3%,比率从NCD前的16.8%增加到NCD后的27.4%.
- 如果在独立实验室进行 (OR 2.76) 或对更多的基因 (OR 1.32) 进行索赔,则更有可能被拒绝.
结论:
- 根据测试地点和类型,NGS测试索赔拒绝率各不相同,并且随着时间的推移而增加,特别是在NCD之后.
- 这些发现表明,尽管有NCD,NGS覆盖范围仍存在不确定性.
- 需要采取政策干预措施,以减少NGS测试的覆盖不确定性和财务责任.
相关概念视频
Next-generation Sequencing
86.1K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.1K
Nursing Ethical Principles II
889
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
889
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


